Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
Biotech
Shionogi pays Apnimed $100M for sleep disorder joint venture
Shionogi is taking full control of its sleep disorder joint venture, agreeing to pay Apnimed $100 million upfront for its partner’s stake.
Nick Paul Taylor
Mar 24, 2026 9:20am
Gilead's $2.2B Ouro buy delivers TCE, new purpose for Galapagos
Mar 24, 2026 3:34am
Embecta to buy auto-injector maker Owen Mumford for $200M
Mar 19, 2026 4:30pm
Alcon, Lensar drop $356M deal after black eye from FTC
Mar 17, 2026 11:00am
Amplifon to buy GN Hearing unit for €2.3B
Mar 16, 2026 10:30am
Agilent makes $950M move to acquire Biocare
Mar 11, 2026 3:00pm
